Anteris Technologies completes treatment of second cohort in first-in-human study for transcatheter heart valve system – Proactive Investors Australia
11:42 Tue 31 May 2022
Anteris Technologies cements position as serious player in TAVR market with in-vivo demonstration of ComASUR™ Transfemoral Delivery System
“We are thrilled with the ongoing progress and the veracity of the results so far. The whole team including the treating physicians are excited by the results so far,” says CEO Wayne Paterson.
Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has completed treatment for the second cohort of an ongoing first-in-human study assessing the efficacy of its’ DurAVR™ transcatheter heart valve (THV) system.
The DurAVR™ aortic replacement valve is designed to address the unmet challenges faced by patients with aortic stenosis, improving their longevity and quality of life by providing a solution with the durability to last the remainder of the patient’s life.
The study is being overseen by chief medical officer Dr Chris Meduri, including the first five aortic stenosis patients implanted with DurAVR in November at the Tbilisi Heart and Vascular Clinic.
Read: Anteris Technologies buoyed by follow-up milestone from first-in-human DurAVR™ heart valve study
Australian physician Dr Karl Poon became the first Australian doctor to perform an implant surgery with DurAVR.
“We are thrilled with the ongoing progress and the veracity of the results so far. The whole team including the treating physicians are excited by the results so far,” Anteris CEO Wayne Paterson said.
“The company continues to progress its clinical program and I look forward to updating the market in the near future.”
Data from this latest cohort will be review at the 30-day follow-up mark, the key inflexion point for indicating ongoing valve performance.
Anteris said all patients enrolled in the study had done exceptionally well.
Add related topics to MyProactive
Create your account: sign up and get ahead on news and events
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is…
In exchange for publishing services rendered by the Company on behalf of Anteris Technologies Ltd named herein, including the promotion by the Company of Anteris Technologies Ltd in any Content on the Site, the…
Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF)'s Wayne Paterson speaks to Proactive about a US$20 million investment from Perceptive Advisors. He says the deal has been in the works for a couple of years and provides a substantial funding runway as it works to bring its durable heart valve…
Prev article
Next article
Only registered members can use this feature.
or
Copyright © Proactive Group Holdings Inc, 2022
All Rights Reserved – Proactive Australia PTY LTD ACN:132787654 ABN:19132787654.
Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which sections of the website you find most interesting and useful. See our Cookie Policy for more information.
Strictly Necessary and Functional
These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.
Advertising
Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.
Performance
Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.